Enzyme-linked Immunoassay for Human Immunodeficiency Virus Type 1 Envelope Glycoprotein 120

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1991 Jan 1

PMID 1993748

Citations 25

Authors

M Gilbert

J Kirihara

J Mills

Affiliations

Soon will be listed here.

Abstract

An enzyme-linked immunosorbent assay (ELISA) that can measure picogram quantities of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein 120 (gp120) in cell culture medium or body fluids has been developed. Recombinant, soluble CD4 immobilized in microtiter trays was used to capture gp120, which was then detected with polyclonal sheep antibody to gp120 followed by biotinylated rabbit anti-sheep immunoglobulin G and an avidin-alkaline phosphatase indicator system. With a reference recombinant gp120, the assay showed a linear relationship between optical density and concentrations ranging from 60 to 6,000 pg/100-microliters well; precision of the assay varied with the concentrations and ranged from +/- 40% with amounts smaller than 200 pg to +/- 10% with amounts larger than 200 pg. In a group of coded samples containing 60 pg (approximately 10(7) molecules) of reference gp120, the assay correctly identified the samples as containing gp120 99% of the time, with no false-positive results recorded for blank samples. Recombinant gp120 prepared in another cell culture system demonstrated a binding coefficient 13-fold lower than that of reference gp120. Mixing standard amounts of reference gp120 with increasing concentrations of human sera reduced assay sensitivity, although the linear relationship between gp120 concentration and optical density remained. With this assay we were able to detect gp120 in HIV-1 suspensions prepared from cultured lymphoblastoid cells and in the sera of HIV-1-infected patients. This ELISA for gp120 should be useful for studying the biological role of gp120 in HIV infection.

Citing Articles

MDSC expansion during HIV infection: regulators, ART and immune reconstitution.

Yaseen M, Abuharfeil N, Darmani H Genes Immun. 2024; 25(3):242-253.

PMID: 38605259 DOI: 10.1038/s41435-024-00272-9.

Disruption of the cholinergic anti-inflammatory response by R5-tropic HIV-1 protein gp120.

Rios S, Colon Saez J, Quesada O, Figueroa K, Lasalde Dominicci J J Biol Chem. 2021; 296:100618.

PMID: 33811859 PMC: 8102909. DOI: 10.1016/j.jbc.2021.100618.

Human Immunodeficiency Virus Type 1 and Methamphetamine-Mediated Mitochondrial Damage and Neuronal Degeneration in Human Neurons.

Teodorof-Diedrich C, Spector S J Virol. 2020; 94(20).

PMID: 32796068 PMC: 7527047. DOI: 10.1128/JVI.00924-20.

HIV Associated Neurodegenerative Disorders: A New Perspective on the Role of Lipid Rafts in Gp120-Mediated Neurotoxicity.

Smith L, Kuhn T, Chen J, Bamburg J Curr HIV Res. 2018; 16(4):258-269.

PMID: 30280668 PMC: 6398609. DOI: 10.2174/1570162X16666181003144740.

Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons.

Teodorof-Diedrich C, Spector S J Virol. 2018; 92(22).

PMID: 30158296 PMC: 6206485. DOI: 10.1128/JVI.00993-18.

References

Chirmule N, Kalyanaraman V, Oyaizu N, Pahwa S . Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses. J Acquir Immune Defic Syndr (1988). 1988; 1(5):425-30. View

Ezekowitz R, Kuhlman M, Groopman J, Byrn R . A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med. 1989; 169(1):185-96. PMC: 2189190. DOI: 10.1084/jem.169.1.185. View

Callahan L, Norcross M . Inhibition of soluble CD4 therapy by antibodies to HIV. Lancet. 1989; 2(8665):734-5. DOI: 10.1016/s0140-6736(89)90790-3. View

Mittler R, Hoffmann M . Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science. 1989; 245(4924):1380-2. DOI: 10.1126/science.2571187. View

Ardman B, Kowalski M, Bristol J, Haseltine W, Sodroski J . Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120. J Acquir Immune Defic Syndr (1988). 1990; 3(3):206-14. View

Gomatos P, Stamatos N, Gendelman H, Fowler A, Hoover D, Kalter D . Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells. J Immunol. 1990; 144(11):4183-8. View

Daar E, Li X, Moudgil T, Ho D . High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc Natl Acad Sci U S A. 1990; 87(17):6574-8. PMC: 54579. DOI: 10.1073/pnas.87.17.6574. View

Popovic M, Sarngadharan M, Read E, Gallo R . Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984; 224(4648):497-500. DOI: 10.1126/science.6200935. View

Dalgleish A, Beverley P, Clapham P, Crawford D, Greaves M, Weiss R . The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984; 312(5996):763-7. DOI: 10.1038/312763a0. View

10.

Ratner L, Haseltine W, Patarca R, Livak K, Starcich B, Josephs S . Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 1985; 313(6000):277-84. DOI: 10.1038/313277a0. View

11.

Levy J, Shimabukuro J, McHugh T, Casavant C, Stites D, Oshiro L . AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells. Virology. 1985; 147(2):441-8. DOI: 10.1016/0042-6822(85)90146-1. View

12.

Nicholson J, Cross G, CALLAWAY C, McDougal J . In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol. 1986; 137(1):323-9. View

13.

Gartner S, Markovits P, Markovitz D, Kaplan M, Gallo R, Popovic M . The role of mononuclear phagocytes in HTLV-III/LAV infection. Science. 1986; 233(4760):215-9. DOI: 10.1126/science.3014648. View

14.

Robey W, Arthur L, Matthews T, Langlois A, Copeland T, Lerche N . Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A. 1986; 83(18):7023-7. PMC: 386644. DOI: 10.1073/pnas.83.18.7023. View

15.

McDougal J, Nicholson J, Cross G, Cort S, Kennedy M, Mawle A . Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol. 1986; 137(9):2937-44. View

16.

Lyerly H, Matthews T, Langlois A, Bolognesi D, Weinhold K . Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. Proc Natl Acad Sci U S A. 1987; 84(13):4601-5. PMC: 305138. DOI: 10.1073/pnas.84.13.4601. View

17.

Lasky L, Nakamura G, Smith D, Fennie C, Shimasaki C, Patzer E . Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 1987; 50(6):975-85. DOI: 10.1016/0092-8674(87)90524-1. View

18.

Deen K, McDougal J, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J . A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature. 1988; 331(6151):82-4. DOI: 10.1038/331082a0. View

19.

Pyle S, Bess Jr J, Robey W, Fischinger P, Gilden R, Arthur L . Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells. AIDS Res Hum Retroviruses. 1987; 3(4):387-400. DOI: 10.1089/aid.1987.3.387. View

20.

Moore J, Jarrett R . Sensitive ELISA for the gp120 and gp160 surface glycoproteins of HIV-1. AIDS Res Hum Retroviruses. 1988; 4(5):369-79. DOI: 10.1089/aid.1988.4.369. View